Published in Am J Physiol on April 01, 1989
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov (2008) 4.76
Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med (1998) 2.33
Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol (2006) 1.79
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A (1991) 1.61
Haemodynamic deterioration after treatment with adenosine. Br Heart J (1994) 1.60
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood (2010) 1.56
Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol (2002) 1.50
Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A (1999) 1.36
Methotrexate modulates the kinetics of adenosine in humans in vivo. Ann Rheum Dis (2005) 1.18
Adenosine and cardiac arrhythmias. BMJ (1992) 1.15
Regulation of neutrophil function by adenosine. Arterioscler Thromb Vasc Biol (2012) 1.11
Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol (2012) 1.07
Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J (1993) 1.06
Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest Ophthalmol Vis Sci (2008) 0.99
Mammalian sleep dynamics: how diverse features arise from a common physiological framework. PLoS Comput Biol (2010) 0.98
Going with the flow: methotrexate, adenosine, and blood flow. Ann Rheum Dis (2006) 0.96
Role of adenosine in the sympathetic activation produced by isometric exercise in humans. J Clin Invest (1994) 0.93
Measurement of purine release with microelectrode biosensors. Purinergic Signal (2011) 0.92
Effects of adenosine on the functions of circulating polymorphonuclear leukocytes during hyperdynamic endotoxemia. Infect Immun (1997) 0.91
Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. J Exp Med (1997) 0.90
Role of adenosine in regulating glucose uptake during contractions and hypoxia in rat skeletal muscle. J Physiol (1999) 0.90
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. Nat Nanotechnol (2014) 0.90
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. World J Diabetes (2010) 0.88
Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo. Br J Pharmacol (1996) 0.86
Bench-to-bedside review: adenosine receptors--promising targets in acute lung injury? Crit Care (2008) 0.85
Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men. J Physiol (2008) 0.85
Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo. J Clin Invest (1994) 0.85
Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol (2016) 0.84
Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation. Br J Pharmacol (2008) 0.84
Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation. J Physiol (2005) 0.84
Changes in serum adenosine deaminase activity during normal pregnancy. J Korean Med Sci (2007) 0.83
Pharmacology of coronary vasodilation: a brief review. J Nucl Cardiol (1997) 0.83
Adenosine myocardial perfusion single photon emission computed tomographic stress testing 24-72 h after uncomplicated myocardial infarction. Int J Cardiovasc Imaging (2002) 0.81
Fructose protects murine hepatocytes from tumor necrosis factor-induced apoptosis by modulating JNK signaling. J Biol Chem (2011) 0.81
The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury. Br J Pharmacol (2001) 0.81
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol (2016) 0.80
Nucleoside uptake in rat liver parenchymal cells. Biochem J (1996) 0.80
1,25-Dihydroxy vitamin D and coronary microvascular function. Eur J Nucl Med Mol Imaging (2012) 0.80
The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias. Cell Signal (2016) 0.79
Role of adenosine in diabetic retinopathy. J Ocul Biol Dis Infor (2012) 0.79
Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes. Br J Haematol (2008) 0.79
Graft versus host disease: New insights into A2A receptor agonist therapy. Comput Struct Biotechnol J (2014) 0.79
Glucose decreases extracellular adenosine levels in isolated mouse and rat pancreatic islets. Islets (2012) 0.79
Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis. J Control Release (2015) 0.78
Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues. Tissue Eng Part B Rev (2014) 0.78
Purine import into malaria parasites as a target for antimalarial drug development. Ann N Y Acad Sci (2014) 0.78
Adenosine's usefulness in vascular surgery. Tex Heart Inst J (2007) 0.78
Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. Nat Commun (2017) 0.77
Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients. Invest New Drugs (2007) 0.77
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280. Proc Natl Acad Sci U S A (2016) 0.76
Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. Curr Pharmacogenomics Person Med (2009) 0.76
Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters. J Physiol (2006) 0.76
Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning. Transl Stroke Res (2013) 0.76
Skeletal muscle vasodilation during systemic hypoxia in humans. J Appl Physiol (1985) (2015) 0.76
The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study. PLoS One (2014) 0.75
Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors. J Exp Med (2016) 0.75
Adenosine A1-receptor blockade impairs the ability of rat pups to autoresuscitate from primary apnea during repeated exposure to hypoxia. Physiol Rep (2015) 0.75
Effects of selective carotid body stimulation with adenosine in conscious humans. J Physiol (2016) 0.75
Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy. Heart (1999) 0.75
Substrate and Inhibitor Specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1. Mol Pharmacol (2016) 0.75
Adenosine 2A receptors in acute kidney injury. Acta Physiol (Oxf) (2015) 0.75
Adenosine A2A receptor plays an important role in radiation-induced dermal injury. FASEB J (2015) 0.75
An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts. Pharmaceuticals (Basel) (2013) 0.75
P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy. J Bioenerg Biomembr (2016) 0.75
[Adenosine for treatment of ischemic pain in thromboangiitis obliterans. A case report]. Schmerz (2007) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Control of coronary vascular tone by nitric oxide. Circ Res (1990) 3.64
Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A (2001) 2.96
Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Commun (1988) 2.86
A transcriptional roadmap to wood formation. Proc Natl Acad Sci U S A (2001) 2.85
Myoglobin: A scavenger of bioactive NO. Proc Natl Acad Sci U S A (2001) 2.26
Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res (1998) 1.80
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res (1997) 1.67
Disruption of myoglobin in mice induces multiple compensatory mechanisms. Proc Natl Acad Sci U S A (1999) 1.60
Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch (1977) 1.58
Unilateral postural control of the functionally dominant and nondominant extremities of healthy subjects. J Athl Train (1998) 1.46
Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med (1992) 1.41
Understanding the controversy over the identity of EDRF. Nature (1994) 1.40
Different sites of adenosine formation in the heart. Am J Physiol (1981) 1.39
Contribution of coronary endothelial cells to cardiac adenosine production. Pflugers Arch (1986) 1.38
Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: a possible effect on Ca2+ influx. J Mol Cell Cardiol (1975) 1.30
Biotechnological production of 2-phenylethanol. Appl Microbiol Biotechnol (2002) 1.29
Compartmentation of cardiac adenine nucleotides and formation of adenosine. Pflugers Arch (1976) 1.24
Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol (1988) 1.22
Uptake and metabolism of adenosine by human erythrocyte ghosts. Am J Physiol (1972) 1.20
Evidence for a cell surface adenosine receptor on coronary myocytes and atrial muscle cells. Studies with an adenosine derivative of high molecular weight. Pflugers Arch (1977) 1.20
Activation of CDK-activating kinase is dependent on interaction with H-type cyclins in plants. Plant J (2000) 1.19
Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology (1994) 1.15
Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res (1992) 1.15
Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J (1981) 1.14
Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats. Neuroscience (1996) 1.12
A vascular transport operator. Am J Physiol (1993) 1.11
Energy turnover of vascular endothelial cells. Am J Physiol (1997) 1.11
Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res (1991) 1.10
Release of adenosine, inosine and hypoxanthine from the isolated guinea pig heart during hypoxia, flow-autoregulation and reactive hyperemia. Pflugers Arch (1977) 1.10
Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J Mol Cell Cardiol (1999) 1.10
An investigation of postural control in postoperative anterior cruciate ligament reconstruction patients. J Athl Train (1999) 1.09
Screening of yeasts for the production of the aroma compound 2-phenylethanol in a molasses-based medium. Biotechnol Lett (2003) 1.07
[Hypertension: pro and contra fixed combination therapy. Pro]. Fortschr Med (1998) 1.06
Myoglobin facilitates oxygen diffusion. FASEB J (2001) 1.05
Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. BMJ (1994) 1.05
Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol (1986) 1.03
Formation and salvage of adenosine by macrovascular endothelial cells. Am J Physiol (1993) 1.02
[Longitudinal study of 24-hour blood pressure behavior in pregnancy and puerperium in patients with normal pregnancy, pre-eclampsia and HELLP syndrome]. Z Geburtshilfe Neonatol (1996) 1.01
Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure. Pflugers Arch (1980) 1.01
The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res (1983) 1.00
Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol (2001) 0.99
Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stage. Am J Transplant (2011) 0.98
Electromagnetic articulography: use of alternating magnetic fields for tracking movements of multiple points inside and outside the vocal tract. Brain Lang (1987) 0.98
Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro. Clin Exp Immunol (1973) 0.97
Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr (1984) 0.95
Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion. Circ Res (1988) 0.95
Relationship between myocardial oxygen consumption, coronary flow, and adenosine release in an improved isolated working heart preparation of guinea pigs. Circ Res (1983) 0.95
Enhanced blood pressure variability in eNOS knockout mice. Hypertension (1999) 0.94
Inhibitory action of adenosine on histamine- and dopamine-stimulated cardiac contractility and adenylate cyclase in guinea pigs. Circ Res (1981) 0.94
Continuous arteriovenous haemofiltration. A new kidney replacement therapy. Proc Eur Dial Transplant Assoc (1981) 0.94
Improving 2-phenylethanol and 6-pentyl-α-pyrone production with fungi by microparticle-enhanced cultivation (MPEC). Yeast (2014) 0.91
Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol (1984) 0.90
Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension (1995) 0.89
Formation of S-adenosylhomocysteine in the heart. I: An index of free intracellular adenosine. Circ Res (1988) 0.89
Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cardiol (1984) 0.89
Na(+)-K(+)-ATPase in endothelial cell energetics: 23Na nuclear magnetic resonance and calorimetry study. Am J Physiol (1995) 0.88
Measurement of the endogenous adenosine concentration in humans in vivo: methodological considerations. Curr Drug Metab (2008) 0.87
A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther (2004) 0.87
Adaptive mechanisms of the cardiovascular system in transgenic mice--lessons from eNOS and myoglobin knockout mice. Basic Res Cardiol (2000) 0.86
Endothelial nitric oxide synthase and LTP. Nature (1997) 0.86
An aqueous-organic two-phase bioprocess for efficient production of the natural aroma chemicals 2-phenylethanol and 2-phenylethylacetate with yeast. Appl Microbiol Biotechnol (2006) 0.86
Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ Res (1993) 0.86
Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol (1984) 0.86
Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci (2000) 0.86
Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium. Arzneimittelforschung (1985) 0.86
Production of the aroma chemicals 3-(methylthio)-1-propanol and 3-(methylthio)-propylacetate with yeasts. Appl Microbiol Biotechnol (2008) 0.85
Insulin effects on myocardial function and bioenergetics in L-bupivacaine toxicity in the isolated rat heart. Eur J Anaesthesiol (2007) 0.85
Glutamate degradation in the ischemic dog heart: contribution to anaerobic energy production. J Mol Cell Cardiol (1989) 0.85
Cloning of the rat P2u receptor and its potential role in coronary vasodilation. Am J Physiol (1996) 0.85
Role of purines in acetylcholine-induced coronary vasodilation. J Mol Cell Cardiol (1982) 0.85
Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. J Mol Cell Cardiol (2005) 0.84
Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc Res (1991) 0.84
Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc Res (1997) 0.84
Unaltered radial maze performance and brain acetylcholine of the endothelial nitric oxide synthase knockout mouse. Neuroscience (2001) 0.83
Evidence for adenylate cyclase-coupled A1-adenosine receptors on ventricular cardiomyocytes from adult rat and dog heart. Life Sci (1987) 0.83
Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium. Res Exp Med (Berl) (1981) 0.82
Spatial heterogeneity of energy turnover in the heart. Pflugers Arch (2001) 0.82
Coxsackie-and-adenovirus receptor mRNA expression in human heart failure. J Gene Med (2003) 0.82
Release of adenosine and cyclic AMP from coronary endothelium in isolated guinea pig hearts: relation to coronary flow. Circ Res (1987) 0.82
Hypoxia-induced activation of KATP channels limits energy depletion in the guinea pig heart. Am J Physiol (1995) 0.82
[Blood pressure variability and transient myocardial ischemia in patients with essential hypertension]. Z Kardiol (1992) 0.81
Mice deficient in endothelial nitric oxide synthase exhibit a selective deficit in hippocampal long-term potentiation. Neuroscience (1999) 0.81
Myocardial ferritin content is closely related to the degree of ischaemia. Acta Physiol Scand (2004) 0.81
Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. J Neurophysiol (1999) 0.81
Spatial heterogeneity of myocardial perfusion and metabolism. Basic Res Cardiol (1998) 0.81
Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia. J Auton Nerv Syst (1985) 0.81
Role of nitric oxide in local blood flow control in the anaesthetized dog. Pflugers Arch (1992) 0.81
Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J Mol Cell Cardiol (1989) 0.81
Mechanisms of ischemic injury in the heart. Basic Res Cardiol (1985) 0.81
Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice. Br J Pharmacol (2002) 0.80
Oxygen partial pressure and free intracellular adenosine of isolated cardiomyocytes. Am J Physiol (1991) 0.80
Comprehensive model of transport and metabolism of adenosine and S-adenosylhomocysteine in the guinea pig heart. Circ Res (1992) 0.80
A modified regionally ischemic porcine heart preparation with eligible residual blood flows. Basic Res Cardiol (1986) 0.80